IL-6 as a major character both involved in “cytokine storm” after CPB and severe COVID-19 pneumonia may be a potential target therapy and prognostic value in COVID-19 patient who undergo cardiac surgery at greater risk to develop post-surgical adverse outcomes. Here, IL6 is linked to COVID-19.